Current and historical daily PE Ratio for Walvax Biotechnology Co Ltd (
) from 2011 to May 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Walvax Biotechnology stock (SZSE:300142) PE ratio as of May 26 2024 is 83.44.
More Details
Walvax Biotechnology Co Ltd (SZSE:300142) PE Ratio (TTM) Chart
Walvax Biotechnology Co Ltd (SZSE:300142) PE Ratio (TTM) Historical Data
View and export this data going back to 2011. Start your Free Trial
Total 1191
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Walvax Biotechnology PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-27 | 83.4 | 2024-03-18 | 69.5 |
| 2024-05-24 | 83.4 | 2024-03-15 | 69.2 |
| 2024-05-23 | 85.8 | 2024-03-14 | 69.6 |
| 2024-05-22 | 87.9 | 2024-03-13 | 70.5 |
| 2024-05-21 | 87.1 | 2024-03-12 | 71.0 |
| 2024-05-20 | 88.9 | 2024-03-11 | 67.8 |
| 2024-05-17 | 89.0 | 2024-03-08 | 65.8 |
| 2024-05-16 | 88.1 | 2024-03-07 | 66.2 |
| 2024-05-15 | 88.2 | 2024-03-06 | 69.0 |
| 2024-05-14 | 90.8 | 2024-03-05 | 70.0 |
| 2024-05-13 | 90.6 | 2024-03-04 | 71.5 |
| 2024-05-10 | 92.5 | 2024-03-01 | 71.0 |
| 2024-05-09 | 94.5 | 2024-02-29 | 70.5 |
| 2024-05-08 | 92.8 | 2024-02-28 | 68.6 |
| 2024-05-07 | 92.6 | 2024-02-27 | 70.7 |
| 2024-05-06 | 91.8 | 2024-02-26 | 69.7 |
| 2024-04-30 | 90.3 | 2024-02-23 | 70.0 |
| 2024-04-29 | 91.0 | 2024-02-22 | 70.1 |
| 2024-04-26 | 87.9 | 2024-02-21 | 69.0 |
| 2024-04-25 | 84.9 | 2024-02-20 | 68.3 |
| 2024-04-24 | 86.8 | 2024-02-19 | 68.0 |
| 2024-04-23 | 87.4 | 2024-02-08 | 67.5 |
| 2024-04-22 | 87.7 | 2024-02-07 | 66.7 |
| 2024-04-19 | 85.8 | 2024-02-06 | 65.8 |
| 2024-04-18 | 87.5 | 2024-02-05 | 60.6 |
| 2024-04-17 | 87.2 | 2024-02-02 | 61.1 |
| 2024-04-16 | 83.9 | 2024-02-01 | 64.1 |
| 2024-04-15 | 87.2 | 2024-01-31 | 63.2 |
| 2024-04-12 | 88.5 | 2024-01-30 | 66.2 |
| 2024-04-11 | 90.1 | 2024-01-29 | 68.2 |
| 2024-04-10 | 91.8 | 2024-01-26 | 70.9 |
| 2024-04-09 | 94.3 | 2024-01-25 | 75.1 |
| 2024-04-08 | 92.1 | 2024-01-24 | 73.2 |
| 2024-04-03 | 96.1 | 2024-01-23 | 73.0 |
| 2024-04-02 | 96.9 | 2024-01-22 | 72.9 |
| 2024-04-01 | 98.5 | 2024-01-19 | 75.4 |
| 2024-03-29 | 94.4 | 2024-01-18 | 77.2 |
| 2024-03-28 | 95.2 | 2024-01-17 | 77.9 |
| 2024-03-27 | 59.2 | 2024-01-16 | 82.8 |
| 2024-03-26 | 61.5 | 2024-01-15 | 83.3 |
| 2024-03-25 | 62.3 | 2024-01-12 | 83.1 |
| 2024-03-22 | 64.2 | 2024-01-11 | 83.8 |
| 2024-03-21 | 66.9 | 2024-01-10 | 83.0 |
| 2024-03-20 | 68.0 | 2024-01-09 | 84.0 |
| 2024-03-19 | 68.3 | 2024-01-08 | 83.7 |
Walvax Biotechnology Co Ltd (SZSE:300142) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Walvax Biotechnology Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE100000WN2
Share Class Description:
SZSE:300142: Class ACompare
Compare
Traded in other countries / regions
300142.China IPO Date
2011-03-10Description
Walvax Biotechnology Co Ltd biological pharmaceutical enterprise engaged in research and development, production and sales of bio-medicine products. It offers bio-medicines, such as vaccines, blood products, and others. The company's products include Haemophilus influenza type b conjugate vaccines, freeze-dried group A, C meningococcal polysaccharide conjugate vaccines, group ACYW135 meningococcal polysaccharide vaccines, and group A and C meningococcal polysaccharide vaccines.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers